Subspecialty Programs
The Alzheimer's Disease and Memory Disorders Center
Validation of Imaging Evaluations in Individuals with Alzheimer's Disease (VIEW-AD) Studies
Site Principal Investigator: Brian R. Ott, MD
What are the VIEW-AD Studies?
The primary goal of these studies is to evaluate multiple
brain imaging markers for Alzheimer's disease and identify single
photon emission computed tomography (SPECT) compounds that most clearly
distinguish Alzheimer's disease from healthy persons of similar
age. Clinical assessments are performed the Alzheimer's Disease
& Memory Disorders Center. SPECT studies are performed
off-site at the brain imaging facility in New Haven, CT. Contact
Lindsay Miller at 444-0789.